Corporate Profile
iRhythm is a digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining our wearable biosensing technology with cloud-based data analytics and machine- learning capabilities. Our goal is to be the leading provider of first-line ambulatory electrocardiogram, or ECG, monitoring for patients at risk for arrhythmias.

We have created a unique platform, ZIO by iRhythm, which we believe allows physicians to diagnose many arrhythmias more quickly and efficiently than traditional technologies, avoiding multiple indeterminate tests, allowing for appropriate medical intervention and potentially avoiding more serious downstream medical events, including stroke.
IRTC (Common Stock)
ExchangeNASDAQ (US Dollar)
Change (%) Stock is Down 0.3 (0.74%)
Data as of 06/27/17 4:00 p.m. ET
Refresh quote
Data provided by Nasdaq. Minimum 15 minutes delayed.
Stock chart for: IRTC.O.  Currently trading at $40.31 with a 52 week high of $41.43 and a 52 week low of $22.16.
Recent News
06/21/17New Expert Statement Recognizes Patch Monitors Such as Zio by iRhythm as Effective for Atrial Fibrillation Monitoring Post-AblationPrinter Friendly Version
05/18/17New Study Confirms Extended Continuous Cardiac Monitoring is More Efficient than Holter Monitoring for Cryptogenic Stroke PatientsPrinter Friendly Version
05/03/17iRhythm Technologies Announces First Quarter 2017 Financial ResultsPrinter Friendly Version
Upcoming Events
There are currently no events scheduled.